Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma.

Frontiers in Oncology
Tao LiuHai Jin

Abstract

Esophageal squamous cell carcinoma (ESCC) is lethal as tumors are rarely detected at an early stage and have a high recurrence rate. There are no particularly useful biomarkers for the prognostic prediction of ESCC. Circulating tumor DNA (ctDNA) is becoming an important biomarker for non-invasive diagnosis and monitoring tumor prognosis. Here, we aimed to analyze variations in plasma cell-free DNA (cfDNA) amount to search for minimal residual disease (MRD). Plasma and white blood cells (WBCs) of 60 patients were collected before tumor resection and a week after surgery. Tumor specimens were also collected as formalin-fixed paraffin-embedded (FFPE) samples. All samples were extracted to analyze the genetic alterations of 61 genes using capture-based next-generation sequencing (NGS). Tumor variants were detected in 38 patients with ESCC, and the two driver genes with the highest mutation frequency were TP53 and PIK3CA. Of the pre-surgical plasma cfDNA samples, 73.7% of identified variants matched the tissue. In patients who did not receive adjuvant therapy after surgery, postoperative cfDNA-positive patients had shorter overall survival (hazard ratios (HR), 25.8; 95% CI, 2.7-242.6; P = 0.004) and were more likely to relapse than ...Continue Reading

References

Apr 1, 1994·International Journal of Cancer. Journal International Du Cancer·T SoussiB Schlichtholz
Nov 5, 1999·Advances in Cancer Research·P Hainaut, M Hollstein
Nov 22, 2005·Journal of Surgical Oncology·Linetta B KoppertWinand N M Dinjens
Oct 31, 2006·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·D Vallböhmer, H-J Lenz
Aug 4, 2007·International Journal of Cancer. Journal International Du Cancer·Toru HiyamaKazuaki Chayama
Aug 2, 2008·Nature Medicine·Frank DiehlLuis A Diaz
Jan 19, 2010·Bioinformatics·Heng Li, Richard Durbin
Jul 23, 2013·PLoS Computational Biology·Umadevi PailaAaron R Quinlan
Jan 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luis A Diaz, Alberto Bardelli
Aug 26, 2014·Nature Genetics·Yi-Bo GaoJie He
Aug 28, 2015·Science Translational Medicine·Isaac Garcia-MurillasNicholas C Turner
Nov 4, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michail IgnatiadisStefanie S Jeffrey
Feb 14, 2016·Gastroenterology·Genta SawadaKoshi Mimori
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jun 26, 2017·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Dakai ZhangBaosheng Li
Jan 20, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·X C LiK X Chen
Aug 9, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hong YangUNKNOWN AME Thoracic Surgery Collaborative Group
Aug 11, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rajiv RajaKoustubh Ranade
Mar 13, 2019·Proceedings of the National Academy of Sciences of the United States of America·Chunfeng QuYuchen Jiao
Apr 18, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raoul Charles CoombesJaqueline A Shaw
May 31, 2019·Nature·Stephen CristianoVictor E Velculescu
Jan 31, 2020·Molecular Cancer Research : MCR·Kelly C S OliveiraDanielle Queiroz Calcagno
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T ReinertC L Andersen

❮ Previous
Next ❯

Software Mentioned

SPSS
Burrows Alignment
Firefly
Act
GEMINI
GraphPad Prism
Accu
VarDict

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.